What is Nucor's earnings per share (EPS)?

Nucor (NUE) reported diluted earnings per share of $7.52 for fiscal year 2025. This represents a -11.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nucor (NUE) Financials

NUE

FY2025 annual

Revenue $32.5B +5.7% YoY

Net Income $1.7B -14.0% YoY

EPS (Diluted) $7.52 -11.1% YoY

Free Cash Flow -$188.0M -123.3% YoY

Market Cap $58.2B as of Sep 8, 2026

Price / Sales 1.8x on $32.5B revenue, FY2025

Price / Earnings 33.4x on $1.7B net income, FY2025

Price / Book 2.6x on $22.1B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 4, 2026 Reported Aug 12, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NUE SEC filings page.

Nucor (NUE) reported $32.5B in revenue for fiscal year 2025, up 5.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NUE FY2025 2026-08-29

Nucor’s dominant mechanic is cyclical margin compression, with heavy reinvestment now consuming the cash generated by profitable operations.

Gross margin fell to 11.9% from 30.1% while revenue later recovered from its FY2024 level; that combination points to weaker economics rather than a simple volume pattern. FY2025 operating cash flow of $3.2B fell short of $3.4B in capital spending, turning positive earnings into negative free cash flow.

FY2025 liabilities of $13.0B were well below $20.9B of equity, so the earnings downturn is occurring without a debt-dominated capital structure. The current ratio recovered to 2.9x from 2.5x in FY2024 as current liabilities fell, indicating improved liquidity through liability reduction rather than a larger current-asset base.

FY2025 shareholder distributions totaled $1.2B through buybacks and dividends while free cash flow was -$188M, so distributions exceeded that year’s internally generated cash. The combination of capital intensity and ongoing distributions helps explain why positive net income did not translate into cash available after investment.

Financial Health Signals

Financial Health Score 34/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Nucor's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Nucor, and counted as zero in the overall score.

Growth

Nucor's revenue grew 5.7% year-over-year to $32.5B, a solid pace of expansion. This earns a growth score of 20/100.

Leverage

Nucor carries a low D/E ratio of 0.33, meaning only $0.33 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 68/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 2.94, Nucor holds $2.94 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 78/100.

Cash Flow

While Nucor generated $3.2B in operating cash flow, capex of $3.4B consumed most of it, leaving -$188.0M in free cash flow. This results in a low score of 38/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Not available for Nucor, and counted as zero in the overall score.

Piotroski F-Score Neutral

6/9

Nucor passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.85x

For every $1 of reported earnings, Nucor generates $1.85 in operating cash flow ($3.2B OCF vs $1.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$10.4B

YoY+23.0%

QoQ+9.5%

5Y CAGR+13.1%

10Y CAGR+7.4%

Nucor generated $10.4B in revenue in Q3 2026. This represents an increase of 23.0% from the same quarter a year earlier. Against the prior quarter it is up 9.5%.

Net Income

$1.2B

YoY+91.7%

QoQ+55.6%

5Y CAGR+124.4%

10Y CAGR+26.4%

Nucor reported $1.2B in net income in Q3 2026. This represents an increase of 91.7% from the same quarter a year earlier. Against the prior quarter it is up 55.6%.

EPS (Diluted)

$5.04

YoY+93.8%

QoQ+56.0%

5Y CAGR+135.2%

10Y CAGR+30.6%

Nucor earned $5.04 per diluted share (EPS) in Q3 2026. This represents an increase of 93.8% from the same quarter a year earlier. Against the prior quarter it is up 56.0%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow

$829.0M

YoY+473.4%

QoQ+268.4%

Nucor generated $829.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 473.4% from the same quarter a year earlier. Against the prior quarter it is up 268.4%.

Cash & Debt

$2.5B

YoY+27.3%

QoQ+11.3%

5Y CAGR+14.8%

10Y CAGR+8.0%

Nucor held $2.5B in cash against $6.4B in long-term debt as of Q3 2026.

Dividends Per Share

$0.56

YoY+1.8%

QoQ0.0%

5Y CAGR+6.8%

10Y CAGR+4.2%

Nucor paid $0.56 per share in dividends in Q3 2026. This represents an increase of 1.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

227M

YoY-1.2%

QoQ-0.4%

5Y CAGR-5.5%

10Y CAGR-3.3%

Nucor had 227M shares outstanding in Q3 2026. This represents a decrease of 1.2% from the same quarter a year earlier. Against the prior quarter it is down 0.4%.

Margins & Returns

Gross Margin

19.6%

YoY+5.1pp

QoQ+3.8pp

5Y CAGR+8.4pp

10Y CAGR+12.2pp

Nucor's gross margin was 19.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 5.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Net Margin

11.1%

YoY+4.0pp

QoQ+3.3pp

5Y CAGR+10.8pp

10Y CAGR+8.9pp

Nucor's net profit margin was 11.1% in Q3 2026, showing the share of revenue converted to profit. This is up 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.3 percentage points.

Return on Equity

5.2%

YoY+2.3pp

QoQ+1.8pp

5Y CAGR+5.0pp

10Y CAGR+3.8pp

Nucor's ROE was 5.2% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks

$350.0M

YoY+75.0%

QoQ+180.0%

5Y CAGR+54.7%

Nucor spent $350.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 75.0% from the same quarter a year earlier. Against the prior quarter it is up 180.0%.

Capital Expenditures

$571.0M

YoY-40.1%

QoQ-13.6%

5Y CAGR+6.5%

10Y CAGR+8.3%

Nucor invested $571.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 40.1% from the same quarter a year earlier. Against the prior quarter it is down 13.6%.

R&D Spending

Not reported for Q3 2026.

NUE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NUE quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$32.5B+5.7%	$30.7B-11.5%	$34.7B-16.4%	$41.5B+13.8%	$36.5B+81.2%	$20.1B-10.8%	$22.6B-9.9%	$25.1B+23.8%	$20.3B+25.0%	$16.2B-1.4%	$16.4B-22.1%	$21.1B+10.8%	$19.1B-1.9%	$19.4B-3.0%	$20.0B
Cost of Revenue	$28.6B+7.4%	$26.6B-1.0%	$26.9B-7.3%	$29.0B+13.9%	$25.5B+42.1%	$17.9B-10.0%	$19.9B-4.2%	$20.8B+17.5%	$17.7B+24.7%	$14.2B-7.5%	$15.3B-20.4%	$19.3B+9.2%	$17.6B-1.5%	$17.9B-1.2%	$18.1B
Gross Profit	$3.9B-5.5%	$4.1B-47.5%	$7.8B-37.5%	$12.5B+13.4%	$11.0B+394.9%	$2.2B-16.8%	$2.7B-37.6%	$4.3B+67.2%	$2.6B+26.8%	$2.0B+81.9%	$1.1B-39.8%	$1.8B+31.1%	$1.4B-6.8%	$1.5B-19.6%	$1.9B
SG&A Expenses	$1.2B+8.5%	$1.1B-29.1%	$1.6B-20.6%	$2.0B+17.0%	$1.7B+177.5%	$615.0M-13.5%	$711.2M-17.4%	$860.7M+25.2%	$687.5M+15.2%	$596.8M+30.0%	$459.0M-11.9%	$520.8M+11.3%	$467.9M+2.9%	$454.9M+3.5%	$439.5M
Interest Expense	$170.0M-25.4%	$228.0M-7.3%	$246.0M+12.3%	$219.0M+34.3%	$163.1M-2.1%	$166.6M+5.9%	$157.4M-2.4%	$161.3M-13.9%	$187.3M+3.4%	$181.2M+2.0%	$177.5M+2.0%	$174.1M+14.6%	$152.0M-12.4%	$173.5M-3.0%	$178.8M
Income Tax	$530.0M-9.1%	$583.0M-57.1%	$1.4B-37.2%	$2.2B+4.2%	$2.1B+424281.2%	-$490K-100.1%	$411.9M-45.0%	$748.3M+102.6%	$369.4M-7.2%	$398.2M+715.5%	$48.8M-86.8%	$368.7M+79.3%	$205.6M-20.9%	$259.8M-33.5%	$390.8M
Net Income	$1.7B-14.0%	$2.0B-55.2%	$4.5B-40.5%	$7.6B+11.4%	$6.8B+846.3%	$721.5M-43.2%	$1.3B-46.2%	$2.4B+79.0%	$1.3B+65.6%	$796.3M+886.4%	$80.7M-88.1%	$679.3M+39.2%	$488.0M-3.3%	$504.6M-35.2%	$778.2M
EPS (Basic)	$7.53-11.1%	$8.47-53.1%	$18.05-37.5%	$28.88+24.3%	$23.23+880.2%	$2.37-42.8%	$4.14-44.4%	$7.44+81.0%	$4.11+65.7%	$2.48+892.0%	$0.25-88.2%	$2.12+39.5%	$1.52-3.8%	$1.58-35.5%	$2.45
EPS (Diluted)	$7.52-11.1%	$8.46-53.0%	$18.00-37.5%	$28.79+24.3%	$23.16+881.4%	$2.36-43.0%	$4.14-44.2%	$7.42+81.0%	$4.10+65.3%	$2.48+892.0%	$0.25-88.2%	$2.11+38.8%	$1.52-3.8%	$1.58-35.5%	$2.45
Diluted Shares (Avg)	231M-3.1%	239M-4.8%	250M-4.9%	263M-10.3%	293M-3.3%	303M-0.7%	306M-3.5%	317M-1.3%	321M+0.3%	320M-0.3%	321M+0.2%	320M+0.3%	319M+0.3%	318M+0.3%	317M

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$10.4B+23.0%	$9.5B+21.3%	$8.5B+20.4%	$8.5B+13.6%	$7.8B-3.1%	$7.1B-8.2%	$7.4B-15.2%	$8.1B-7.3%
Cost of Revenue	$8.4B+15.6%	$8.0B+10.7%	$7.3B	$7.2B+8.2%	$7.2B+5.0%	N/A	$6.7B-2.5%	$6.9B+2.6%
Gross Profit	$2.0B+66.3%	$1.5B+148.1%	$1.2B+89.5%	$1.2B+61.3%	$605.0M-49.3%	$627.0M-55.0%	$758.0M-60.5%	$1.2B-40.2%
SG&A Expenses	$405.0M+33.2%	$378.0M+34.5%	$300.0M	$304.0M+24.6%	$281.0M-4.4%	N/A	$244.0M-36.7%	$294.0M-24.6%
Interest Expense	$36.0M-26.5%	$39.0M-23.5%	$38.0M	$49.0M-24.6%	$51.0M-23.9%	N/A	$65.0M+2.8%	$67.0M+6.9%
Income Tax	$345.0M+78.8%	$226.0M+283.1%	$200.0M	$193.0M+124.4%	$59.0M-68.3%	N/A	$86.0M-73.7%	$186.0M-49.1%
Net Income	$1.2B+91.7%	$743.0M+376.3%	$607.0M+111.5%	$603.0M+141.2%	$156.0M-75.8%	$287.0M-63.4%	$250.0M-78.1%	$645.0M-43.3%
EPS (Basic)	$5.05+94.2%	$3.23+382.1%	$2.63+115.6%	$2.60+147.6%	$0.67-75.0%	$1.22-61.5%	$1.05-77.1%	$2.68-40.0%
EPS (Diluted)	$5.04+93.8%	$3.23+382.1%	$2.63+115.6%	$2.60+147.6%	$0.67-75.0%	$1.22-61.4%	$1.05-77.0%	$2.68-39.8%
Diluted Shares (Avg)	229M-1.0%	229M-1.5%	230M	231M-2.5%	233M-3.0%	N/A	237M-4.9%	240M-5.7%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

NUE Balance Sheet

NUE quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$35.1B+3.4%	$33.9B-4.0%	$35.3B+8.8%	$32.5B+25.8%	$25.8B+28.3%	$20.1B+9.7%	$18.3B+2.4%	$17.9B+13.1%	$15.8B+4.1%	$15.2B+6.3%	$14.3B-10.2%	$16.0B+5.0%	$15.2B+7.4%	$14.2B-2.9%	$14.6B
Current Assets	$11.8B-5.7%	$12.5B-23.9%	$16.4B+11.5%	$14.7B+14.8%	$12.8B+34.9%	$9.5B+15.3%	$8.2B-4.7%	$8.6B+26.5%	$6.8B+4.9%	$6.5B+11.1%	$5.9B-9.1%	$6.4B+0.5%	$6.4B+13.2%	$5.7B-15.6%	$6.7B
Cash & Equivalents	$2.3B-36.5%	$3.6B-44.3%	$6.4B+49.1%	$4.3B+81.0%	$2.4B-10.4%	$2.6B+72.0%	$1.5B+9.7%	$1.4B+47.4%	$949.1M-53.6%	$2.0B+5.5%	$1.9B+89.4%	$1.0B-31.0%	$1.5B+40.9%	$1.1B-12.3%	$1.2B
Short-Term Investments	$439.0M-24.4%	$581.0M-22.2%	$747.0M+29.5%	$576.9M+128.0%	$253.0M-38.0%	$408.0M+36.0%	$300.0M	$0-100.0%	$50.0M-66.7%	$150.0M+50.0%	$100.0M0.0%	$100.0M+254.7%	$28.2M-72.9%	$104.2M-92.4%	$1.4B
Inventory	$5.5B+7.0%	$5.1B-8.5%	$5.6B+2.3%	$5.5B-9.3%	$6.0B+68.4%	$3.6B-7.1%	$3.8B-15.6%	$4.6B+31.5%	$3.5B+39.6%	$2.5B+10.4%	$2.2B-18.2%	$2.7B+5.4%	$2.6B+12.1%	$2.3B+16.9%	$2.0B
Accounts Receivable	$3.1B+16.1%	$2.7B-9.4%	$3.0B-17.8%	$3.6B-6.8%	$3.9B+67.6%	$2.3B+6.4%	$2.2B-13.8%	$2.5B+23.5%	$2.0B+24.3%	$1.6B+17.9%	$1.4B-33.1%	$2.1B+14.2%	$1.8B+6.1%	$1.7B-0.2%	$1.7B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.3B+0.2%	$4.3B+8.0%	$4.0B+1.3%	$3.9B+38.6%	$2.8B+26.8%	$2.2B+1.3%	$2.2B+0.8%	$2.2B-0.5%	$2.2B+7.0%	$2.1B+2.1%	$2.0B-2.8%	$2.1B+4.8%	$2.0B-1.5%	$2.0B+9.5%	$1.8B
Total Liabilities	$13.0B+3.6%	$12.5B-5.3%	$13.2B+2.4%	$12.9B+15.1%	$11.2B+26.2%	$8.9B+17.7%	$7.6B-2.1%	$7.7B+14.2%	$6.8B-3.0%	$7.0B+7.6%	$6.5B-14.1%	$7.5B+3.4%	$7.3B+16.4%	$6.3B-8.7%	$6.9B
Current Liabilities	$4.0B-19.5%	$5.0B+8.3%	$4.6B+6.1%	$4.3B-16.0%	$5.2B+96.3%	$2.6B+6.7%	$2.5B-12.2%	$2.8B-0.7%	$2.8B+18.2%	$2.4B+72.5%	$1.4B-34.0%	$2.1B+7.0%	$2.0B-3.4%	$2.0B-15.3%	$2.4B
Non-Current Liabilities	$9.0B+19.0%	$7.5B-12.5%	$8.6B+0.5%	$8.6B+41.5%	$6.1B-3.3%	$6.3B+23.1%	$5.1B+3.6%	$4.9B+24.9%	$3.9B-14.1%	$4.6B-10.1%	$5.1B-6.5%	$5.4B+2.1%	$5.3B+25.9%	$4.2B-5.2%	$4.5B
Long-Term Debt	$6.9B+21.6%	$5.7B-14.5%	$6.6B+0.5%	$6.6B+33.3%	$5.0B-5.9%	$5.3B+22.8%	$4.3B+1.4%	$4.2B+30.6%	$3.2B-13.3%	$3.7B-13.8%	$4.3B-0.5%	$4.4B-0.4%	$4.4B+29.5%	$3.4B-6.9%	$3.6B
Total Equity	$20.9B+3.2%	$20.3B-3.1%	$20.9B+13.7%	$18.4B+31.4%	$14.0B+29.9%	$10.8B+4.2%	$10.4B+5.8%	$9.8B+12.0%	$8.7B+10.9%	$7.9B+5.4%	$7.5B-3.8%	$7.8B+1.7%	$7.6B+0.1%	$7.6B+2.2%	$7.5B
Retained Earnings	$31.5B+4.1%	$30.3B+5.2%	$28.8B+16.2%	$24.8B+40.1%	$17.7B+55.8%	$11.3B+2.1%	$11.1B+7.5%	$10.3B+22.1%	$8.5B+10.9%	$7.6B+4.3%	$7.3B-0.8%	$7.4B+3.3%	$7.1B+0.2%	$7.1B+0.2%	$7.1B

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$37.0B+8.0%	$35.6B+2.7%	$34.8B+2.5%	$34.2B-0.4%	$34.7B+1.5%	$33.9B-4.0%	$34.3B+0.2%	$34.2B+6.0%
Current Assets	$13.2B+12.3%	$12.1B-5.3%	$11.8B-5.3%	$11.7B-13.3%	$12.8B-10.5%	$12.5B-23.9%	$13.5B-15.2%	$14.3B-0.4%
Cash & Equivalents	$2.5B+27.3%	$2.2B-29.5%	$2.2B-37.6%	$1.9B-54.3%	$3.2B-32.0%	$3.6B-44.3%	$4.3B-27.2%	$4.6B+22.1%
Short-Term Investments	$214.0M-60.1%	$255.0M-71.8%	$524.0M-9.8%	$537.0M-9.8%	$905.0M+13.8%	$581.0M-22.2%	$595.6M-31.0%	$795.2M-2.8%
Inventory	$6.0B+10.2%	$5.6B+7.4%	$5.4B+5.6%	$5.5B+6.5%	$5.3B0.0%	$5.1B-8.5%	$5.1B-2.3%	$5.3B-6.0%
Accounts Receivable	$4.0B+19.4%	$3.6B+20.3%	$3.3B+22.9%	$3.4B+14.9%	$3.0B-4.8%	$2.7B-9.4%	$2.9B-14.0%	$3.1B-15.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.3B-0.2%	$4.3B+0.2%	$4.3B+0.1%	$4.3B+0.6%	$4.3B+7.2%	$4.3B+8.0%	$4.3B+9.0%	$4.0B+2.2%
Total Liabilities	$13.7B+7.6%	$13.1B-3.7%	$12.8B+2.6%	$12.7B-0.5%	$13.6B+9.4%	$12.5B-5.3%	$12.8B+0.2%	$12.4B+0.8%
Current Liabilities	$5.2B+26.5%	$4.2B-17.6%	$4.3B-14.5%	$4.1B-20.5%	$5.1B+4.0%	$5.0B+8.3%	$5.2B+21.8%	$4.9B+27.0%
Non-Current Liabilities	$8.4B-1.6%	$8.9B+4.6%	$8.6B+13.8%	$8.6B+13.3%	$8.5B+13.0%	$7.5B-12.5%	$7.6B-10.6%	$7.5B-11.1%
Long-Term Debt	$6.4B-4.5%	$6.9B+2.8%	$6.7B+17.6%	$6.7B+17.7%	$6.7B+18.4%	$5.7B-14.5%	$5.7B-14.1%	$5.6B-14.6%
Total Equity	$22.1B+8.4%	$21.5B+6.9%	$20.8B+2.3%	$20.4B-0.4%	$20.1B-3.2%	$20.3B-3.1%	$20.5B0.0%	$20.7B+9.0%
Retained Earnings	$33.1B+7.7%	$32.1B+6.0%	$31.3B+3.3%	$30.8B+2.2%	$30.3B+1.0%	$30.3B+5.2%	$30.1B+7.1%	$30.0B+16.4%

NUE Cash Flow Statement

NUE quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$3.2B-18.7%	$4.0B-44.1%	$7.1B-29.4%	$10.1B+61.6%	$6.2B+131.0%	$2.7B-4.0%	$2.8B+17.4%	$2.4B+126.8%	$1.1B-39.7%	$1.8B-19.3%	$2.2B+61.5%	$1.3B+24.6%	$1.1B-10.2%	$1.2B+16.4%	$1.0B
Depreciation & Amortization	$1.5B+9.1%	$1.4B+16.0%	$1.2B+10.1%	$1.1B+22.8%	$864.6M+10.1%	$785.5M+6.9%	$734.6M+2.1%	$719.7M-1.0%	$727.0M+5.8%	$687.1M-1.9%	$700.1M-3.4%	$724.4M+18.7%	$610.3M+0.5%	$607.0M+2.8%	$590.4M
Stock-Based Compensation	$133.0M+0.8%	$132.0M+1.5%	$130.0M-5.1%	$137.0M+0.9%	$135.8M+83.8%	$73.9M-18.3%	$90.4M+23.1%	$73.4M+14.4%	$64.2M+13.6%	$56.5M+23.4%	$45.8M-1.3%	$46.4M-2.2%	$47.5M-6.5%	$50.7M+3.5%	$49.0M
Capital Expenditures	$3.4B+7.8%	$3.2B+43.3%	$2.2B+13.7%	$1.9B+20.1%	$1.6B+5.1%	$1.5B+4.5%	$1.5B+50.4%	$982.5M+119.0%	$448.6M-25.8%	$604.8M+61.7%	$374.1M-44.0%	$668.0M-44.2%	$1.2B+26.3%	$947.6M+115.9%	$438.9M
Free Cash Flow	-$188.0M-123.3%	$806.0M-83.5%	$4.9B-39.7%	$8.1B+76.3%	$4.6B+299.5%	$1.2B-13.4%	$1.3B-5.6%	$1.4B+132.6%	$606.8M-47.0%	$1.1B-36.2%	$1.8B+165.9%	$674.9M+667.1%	-$119.0M-147.1%	$252.8M-57.3%	$592.1M
Investing Cash Flow	-$3.2B+13.6%	-$3.7B-49.6%	-$2.5B+56.2%	-$5.7B-98.4%	-$2.9B-62.9%	-$1.8B+1.7%	-$1.8B-74.2%	-$1.0B-12.1%	-$918.9M+10.4%	-$1.0B	N/A	N/A	-$840.0M-311.8%	-$204.0M+69.1%	-$659.9M
Financing Cash Flow	-$1.3B+57.0%	-$3.1B-17.9%	-$2.6B-3.3%	-$2.5B+30.3%	-$3.6B-1360.4%	$285.9M+132.5%	-$880.4M+3.1%	-$908.2M+26.9%	-$1.2B-98.3%	-$626.4M	N/A	N/A	$196.0M+117.1%	-$1.1B-131.7%	-$495.0M
Dividends Paid	$512.0M-1.9%	$522.0M+1.4%	$515.0M-3.6%	$534.0M+10.5%	$483.5M-1.7%	$491.7M-0.1%	$492.1M+1.4%	$485.4M0.0%	$485.3M+0.9%	$481.1M+0.3%	$479.4M+0.9%	$475.1M+0.9%	$471.0M+1.0%	$466.4M+1.0%	$461.5M
Share Buybacks	$700.0M-68.4%	$2.2B+42.7%	$1.6B-43.8%	$2.8B-15.7%	$3.3B+8194.1%	$39.5M-86.8%	$298.5M-65.0%	$854.0M+845.7%	$90.3M+1645.7%	$5.2M-92.2%	$66.5M	$0	$0	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$1.4B+91.3%	$886.0M+143.4%	$1.3B+82.7%	$732.0M-43.7%	$364.0M-75.5%	$733.0M-51.8%	$1.3B-47.2%	$1.5B+23.0%
Depreciation & Amortization	$383.0M+4.6%	$384.0M+4.3%	$367.0M+2.5%	$366.0M+4.6%	$368.0M+10.8%	$358.0M+14.7%	$350.0M+20.4%	$332.0M+18.6%
Stock-Based Compensation	N/A	$30.0M+15.4%	N/A	N/A	$26.0M	N/A	N/A	N/A
Capital Expenditures	$571.0M-40.1%	$661.0M-23.1%	$807.0M-8.2%	$954.0M+15.9%	$859.0M+7.2%	$879.0M+22.5%	$823.0M+87.4%	$801.0M+50.6%
Free Cash Flow	$829.0M+473.4%	$225.0M+145.5%	$532.0M+464.4%	-$222.0M-146.4%	-$495.0M-172.4%	-$146.0M-118.2%	$478.0M-76.4%	$684.0M+1.3%
Investing Cash Flow	-$510.0M+6.1%	-$446.0M+62.2%	-$786.0M+18.5%	-$543.0M+53.6%	-$1.2B-66.0%	-$964.0M-47.1%	-$1.2B-153.6%	-$711.0M+7.6%
Financing Cash Flow	-$632.0M+55.2%	-$472.0M-214.0%	-$273.0M+40.8%	-$1.4B-176.5%	$414.0M+159.9%	-$461.0M-32.2%	-$510.0M+22.1%	-$691.0M+24.9%
Dividends Paid	$129.0M0.0%	$129.0M0.0%	$127.0M-0.8%	$129.0M-0.8%	$129.0M-0.8%	$128.0M+0.8%	$130.0M+1.5%	$130.0M-0.4%
Share Buybacks	$350.0M+75.0%	$125.0M-58.3%	$100.0M-68.4%	$200.0M-50.0%	$300.0M-40.0%	$316.0M+78.3%	$400.0M-20.0%	$500.0M+17.4%

NUE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NUE quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	11.9%-1.4pp	13.4%-9.2pp	22.5%-7.6pp	30.1%-0.1pp	30.2%+19.2pp	11.1%-0.8pp	11.9%-5.3pp	17.1%+4.4pp	12.7%+0.2pp	12.5%+5.7pp	6.8%-2.0pp	8.8%+1.4pp	7.4%-0.4pp	7.8%-1.6pp	9.4%
Net Margin	5.4%-1.2pp	6.6%-6.4pp	13.0%-5.3pp	18.3%-0.4pp	18.7%+15.1pp	3.6%-2.1pp	5.6%-3.8pp	9.4%+2.9pp	6.5%+1.6pp	4.9%+4.4pp	0.5%-2.7pp	3.2%+0.7pp	2.6%0.0pp	2.6%-1.3pp	3.9%
Return on Equity	8.3%-1.7pp	10.0%-11.6pp	21.6%-19.7pp	41.3%-7.4pp	48.7%+42.0pp	6.7%-5.6pp	12.3%-11.8pp	24.1%+9.0pp	15.1%+5.0pp	10.1%+9.0pp	1.1%-7.7pp	8.7%+2.4pp	6.4%-0.2pp	6.6%-3.8pp	10.4%
Return on Assets	5.0%-1.0pp	6.0%-6.8pp	12.8%-10.6pp	23.4%-3.0pp	26.4%+22.9pp	3.6%-3.4pp	6.9%-6.2pp	13.2%+4.9pp	8.3%+3.1pp	5.2%+4.7pp	0.6%-3.7pp	4.3%+1.1pp	3.2%-0.4pp	3.6%-1.8pp	5.3%
Current Ratio	2.94+0.4x	2.51-1.1x	3.57+0.2x	3.39+0.9x	2.48-1.1x	3.61+0.3x	3.34+0.3x	3.08+0.7x	2.42-0.3x	2.72-1.5x	4.23+1.2x	3.07-0.2x	3.27+0.5x	2.790.0x	2.80
Debt-to-Equity	0.330.0x	0.280.0x	0.320.0x	0.360.0x	0.35-0.1x	0.49+0.1x	0.410.0x	0.43+0.1x	0.37-0.1x	0.47-0.1x	0.580.0x	0.560.0x	0.57+0.1x	0.440.0x	0.49
Asset Turnover	0.930.0x	0.91-0.1x	0.98-0.3x	1.28-0.1x	1.41+0.4x	1.00-0.2x	1.23-0.2x	1.40+0.1x	1.28+0.2x	1.06-0.1x	1.15-0.2x	1.32+0.1x	1.25-0.1x	1.370.0x	1.37
FCF Margin	-0.6%-3.2pp	2.6%-11.5pp	14.1%-5.5pp	19.6%+6.9pp	12.6%+6.9pp	5.7%-0.2pp	5.9%+0.3pp	5.6%+2.6pp	3.0%-4.1pp	7.1%-3.9pp	10.9%+7.7pp	3.2%+3.8pp	-0.6%-1.9pp	1.3%-1.7pp	3.0%

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	19.6%+5.1pp	15.8%+8.1pp	13.9%+5.1pp	14.5%+4.3pp	7.7%-7.0pp	8.9%-9.2pp	10.2%-11.7pp	14.8%-8.2pp
Net Margin	11.1%+4.0pp	7.8%+5.8pp	7.1%+3.1pp	7.1%+3.8pp	2.0%-6.0pp	4.1%-6.1pp	3.4%-9.7pp	8.0%-5.1pp
Return on Equity	5.2%+2.3pp	3.5%+2.7pp	2.9%+1.5pp	3.0%+1.7pp	0.8%-2.3pp	1.4%-2.3pp	1.2%-4.4pp	3.1%-2.9pp
Return on Assets	3.1%+1.4pp	2.1%+1.6pp	1.8%+0.9pp	1.8%+1.0pp	0.4%-1.4pp	0.9%-1.4pp	0.7%-2.6pp	1.9%-1.6pp
Current Ratio	2.51-0.3x	2.90+0.4x	2.77+0.3x	2.83+0.2x	2.52-0.4x	2.51-1.1x	2.59-1.1x	2.93-0.8x
Debt-to-Equity	0.290.0x	0.320.0x	0.320.0x	0.33+0.1x	0.33+0.1x	0.280.0x	0.280.0x	0.27-0.1x
Asset Turnover	0.280.0x	0.270.0x	0.240.0x	0.250.0x	0.230.0x	0.210.0x	0.220.0x	0.240.0x
FCF Margin	8.0%+10.6pp	2.4%+8.7pp	6.2%+8.3pp	-2.6%-9.0pp	-6.3%-14.8pp	-2.1%-12.5pp	6.4%-16.6pp	8.5%+0.7pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Nucor NUE	FY2025	$32.5B	$1.7B	5.4%	$58.2B	34/100
Arcelormittal MT	FY2025	$61.4B	$3.2B	5.3%	$59.4B	21/100
Steel Dynamics Inc STLD	FY2025	$18.2B	$1.2B	6.5%	$34.7B	53/100
Reliance Inc RS	FY2025	$14.3B	$739.4M	5.2%	$20.4B	59/100
Ternium TX	FY2025	$15.6B	$303.1M	1.9%	$11.4B	33/100

Where Nucor Ranks

Frequently Asked Questions

What is Nucor's annual revenue?

Nucor (NUE) reported $32.5B in total revenue for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nucor's revenue growing?

Nucor (NUE) revenue grew by 5.7% year-over-year, from $30.7B to $32.5B in fiscal year 2025.

Is Nucor profitable?

Yes, Nucor (NUE) reported a net income of $1.7B in fiscal year 2025, with a net profit margin of 5.4%.

How much debt does Nucor have?

As of fiscal year 2025, Nucor (NUE) had $2.3B in cash and equivalents against $6.9B in long-term debt.

What is Nucor's gross margin?

Nucor (NUE) had a gross margin of 11.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Nucor's net profit margin?

Nucor (NUE) had a net profit margin of 5.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Nucor pay dividends?

Yes, Nucor (NUE) paid $2.21 per share in dividends during fiscal year 2025.

What is Nucor's return on equity (ROE)?

Nucor (NUE) has a return on equity of 8.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Nucor's free cash flow?

Nucor (NUE) recorded an outflow of $188.0M in free cash flow during fiscal year 2025. This represents a -123.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Nucor's operating cash flow?

Nucor (NUE) generated $3.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Nucor's total assets?

Nucor (NUE) had $35.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Nucor's capital expenditures?

Nucor (NUE) invested $3.4B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Nucor buy back shares?

Yes, Nucor (NUE) spent $700.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Nucor have outstanding?

Nucor (NUE) had 228M shares outstanding as of fiscal year 2025.

What is Nucor's current ratio?

Nucor (NUE) had a current ratio of 2.94 as of fiscal year 2025, which is generally considered healthy.

What is Nucor's debt-to-equity ratio?

Nucor (NUE) had a debt-to-equity ratio of 0.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Nucor's return on assets (ROA)?

Nucor (NUE) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Nucor's P/E ratio?

Nucor (NUE) trades at 33.4x earnings, its market capitalization divided by net income of $1.7B net income, FY2025. The market capitalization is $58.2B as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Nucor's price-to-sales ratio?

Nucor (NUE) trades at 1.8x sales, its market capitalization divided by revenue of $32.5B revenue, FY2025. The market capitalization is $58.2B as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Nucor's Piotroski F-Score?

Nucor (NUE) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Nucor's earnings high quality?

Nucor (NUE) has an earnings quality ratio of 1.85x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Nucor?

Nucor (NUE) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.